1-12 of 12
Partow Kebriaei, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Mixed T-Lymphocyte and Myeloid Chimerism Is Predictive of Disease Recurrence Following Allogeneic Stem Cell Transplantation for AML/MDS.

Hans C. Lee, MD, Rima M. Saliba, Ph.D., Gabriela Rondon, MD, Julianne Chen, Yasmeen Charafeddine, L. Jeffrey Medeiros, MD, Marcos De Lima, MD, Borje S Andersson, MD, PhD, Partow Kebriaei, M.D., Betul Oran, MD, MS, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 3075.
https://doi.org/10.1182/blood.V120.21.3075.3075
Published: 2012
Journal Articles

Relevance and Factors Predicting for Early Lymphocyte Recovery After Allogeneic Bone Marrow Stem Cell Transplantation (BMT).

Ulas D. Bayraktar, MD, Rima M Saliba, PhD, Gabriela Rondon, MD, Antonio Di Stasi, MD, Partow Kebriaei, M.D., Marcos de Lima, MD, Richard E. Champlin, Stefan O. Ciurea
Journal: Blood
Blood (2012) 120 (21): 3053.
https://doi.org/10.1182/blood.V120.21.3053.3053
Published: 2012
Journal Articles

EBMT Risk Score for Pre Transplant Risk Assessment in Patients with Multiple Myeloma.

Zartash Gul, MD, Hasan Khan, Qaiser Bashir, MD, Nina Shah, MD, Simrit Parmar, M.D., Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Paolo Anderlini, MD, Elizabeth J Shpall, MD, Sergio Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2012) 120 (21): 3094.
https://doi.org/10.1182/blood.V120.21.3094.3094
Published: 2012
Journal Articles

Multicenter Study of “off-the-Shelf” Third Party Virus-Specific T Cells (VSTs) to Treat Adenovirus (Adv), Cytomegalovirus (CMV) or Epstein Barr Virus (EBV) Infection After Hemopoietic Stem Cell Transplantation (HSCT)

Ann M. Leen, PhD, Catherine M. Bollard, MD, Adam M. Mendizabal, MS, Elizabeth J. Shpall, MD, Paul Szabolcs, MD, Joseph H. Antin, MD, Neena Kapoor, MD, Sung-Yun Pai, MD, Scott D. Rowley, MD, Partow Kebriaei, M.D., Bambi J. Grilley, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD
Journal: Blood
Blood (2012) 120 (21): 457.
https://doi.org/10.1182/blood.V120.21.457.457
Published: 2012
Journal Articles

Outcomes of Adults with Acute Lymphoblastic Leukemia (ALL) Following Relapse After First Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Amir Hamdi, M.D., LM Poon, M.D., Rima M. Saliba, Ph.D., Gabriela Rondon, M.D., Celina Ledesma, Muzaffar Qazilbash, M.D., Chitra M. Hosing, M.D., Roy B. Jones, MD, Ph.D., Uday R. Popat, M.D., Nieto, M.D., Ph.D., Amin M. Alousi, M.D., Stefan O. Ciurea, Elizabeth J. Shpall, M.D., Richard E. Champlin, Partow Kebriaei, M.D.
Journal: Blood
Blood (2012) 120 (21): 4215.
https://doi.org/10.1182/blood.V120.21.4215.4215
Published: 2012
Journal Articles

Experience with 2 Dose Schedules of Inotuzumab Ozogamicin, Single Dose, and Weekly, in Refractory-Relapsed Acute Lymphocytic Leukemia (ALL)

Susan O'Brien, M.D., Deborah A. Thomas, MD, Jeffrey L. Jorgensen, MD, PhD, Partow Kebriaei, M.D., Farhad Ravandi, MD, Monica Kwari, BSN, Stefan Faderl, MD, Jorge E. Cortes, MD, Elias J. Jabbour, MD, Sergernne York, RN, Rebecca Garris, BSc, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2012) 120 (21): 671.
https://doi.org/10.1182/blood.V120.21.671.671
Published: 2012
Journal Articles

Cardiac Toxicity After High-Dose Melphlan and Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Zartash Gul, MD, Qaiser Bashir, MD, Yago Nieto, M.D., Ph.D., Nazeer Sherwani, Simrit Parmar, M.D., Nina Shah, MD, Yvonne T Dinh, Chitra M. Hosing, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Elizabeth J Shpall, MD, Sergio A Giralt, MD, Richard E. Champlin, Muzaffar H. Qazilbash, MD
Journal: Blood
Blood (2012) 120 (21): 2027.
https://doi.org/10.1182/blood.V120.21.2027.2027
Published: 2012
Journal Articles

Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

Christopher B. Benton, MD, Marina Konopleva, MD, PhD, Rima M Saliba, PhD, Elizabeth J. Shpall, MD, Stefan O. Ciurea, Partow Kebriaei, M.D., Amin M. Alousi, M.D., Uday R. Popat, M.D., Paolo Anderlini, MD, Yago Nieto, M.D., Ph.D., Simrit Parmar, M.D., Zhihong Zeng, MD, Julianne J Chen, Gabriela Rondon, MD, Becky McMullin, RN, Rui-Yu Wang, MD, PhD, Hongbo Lu, MMSC, Wendy D. Schober, MLT (ASCP), Glenda G Woodworth, RN, Alison Gulbis, Pharm.D., Rita Cool, Wei Qiao, Peter F Thall, PhD, Michael Andreeff, MD, PhD, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 360.
https://doi.org/10.1182/blood.V120.21.360.360
Published: 2012
Journal Articles

A Matched Controlled Analysis of Post-Transplant Cyclophosphamide (CY) Versus Tacrolimus and Mini-Dose Methotrexate in Matched Sibling and Unrelated Donor Transplant Recipients Receiving Reduced-Intensity Conditioning: Post-Transplant CY Is Associated with Higher Rates of Acute Gvhd

Amin M. Alousi, M.D., Rima M Saliba, PhD, Julianne Chen, Borje S Andersson, MD, PhD, Issa Khouri, MD, Muzaffar H. Qazilbash, MD, Uday R. Popat, M.D., Chitra M. Hosing, M.D., Stefan O. Ciurea, Elizabeth J Shpall, MD, Roy B. Jones, MD, Ph.D., Partow Kebriaei, M.D., Yago Nieto, M.D., Ph.D., Paolo Anderlini, MD, Marcos DeLima, MD, Gabriela Rondon, Richard E. Champlin
Journal: Blood
Blood (2012) 120 (21): 4200.
https://doi.org/10.1182/blood.V120.21.4200.4200
Published: 2012
Journal Articles

Low Dose Azacitidine (AZA) Reduces the Incidence of Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Marcos de Lima, MD, Simrit Parmar, M.D., Julianne J Chen, Sergio A Giralt, MD, Gabriela Rondon, MD, Uday R. Popat, M.D., Amin M. Alousi, M.D., Hans C. Lee, MD, Glenda G Woodworth, RN, Chitra M Hosing, MD, Elizabeth J. Shpall, Partow Kebriaei, M.D., Guillermo garcia Manero, MD, Richard E. Champlin, Rima M. Saliba, Ph.D.
Journal: Blood
Blood (2012) 120 (21): 742.
https://doi.org/10.1182/blood.V120.21.742.742
Published: 2012
Journal Articles

CD19-Specific T Cells for Treatment of Pediatric Acute Lymphocytic Leukemia Using Sleeping Beauty Transposition.

Harjeet Singh, PhD, Pallavi R. Manuri, Ph.D., Simon Olivares, B.S., Navid Dara, B.S., Margaret J. Dawson, B.S., Helen Huls, B.S., Dean A. Lee, M.D., Ph.D., Perry B. Hackett, Ph.D., Donald B. Kohn, M.D., Partow Kebriaei, M.D., Elizabeth J. Shpall, M.D., Richard Champlin, M.D., Laurence Cooper, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2820.
https://doi.org/10.1182/blood.V110.11.2820.2820
Published: 2007
Journal Articles

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Amin M. Alousi, MD, Chitra Hosing, M.D., Rima M. Saliba, PhD., Rosamar B. Valverde, BSN, Farzaneh Maadani, BS, Martin Korbling, M.D., Grace J. Okoroji, MS, Luis E. Fayad, M.D., Anne M. Stachowiak, BS, William D. Erwin, MS, Paolo Anderlini, M.D., Marcos J. de Lima, M.D., Sergio A. Giralt, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Naoto T. Ueno, M.D., Peter W. McLaughlin, M.D., Barbara Pro, M.D., Michael Wang, M.D., Alma Rodriguez, M.D., Fredrick B. Hagemeister, M.D., Homer A. Macapinlac, M.D., Donald A. Podoloff, M.D., Richard E. Champlin, M.D., Issa F. Khouri, M.D.
Journal: Blood
Blood (2007) 110 (11): 620.
https://doi.org/10.1182/blood.V110.11.620.620
Published: 2007